N-Trimethyl chitosan-coated multivesicular liposomes for oxymatrine oral delivery
Authors:
- 16 October 2009
- journal article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 35 (11) , 1339-1347
Abstract
Background: Multivesicular liposomes (MVLs), uncoated and coated with N-trimethyl chitosan (TMC), have been studied for their potential use for drug delivery by the oral route. Method: Synthesized TMC was characterized by infrared spectroscopy, revealing the presence of trimethyl groups, and by proton nuclear magnetic resonance spectroscopy, allowing the calculation of the degree of substitution quaternization (70.2%). Oxymatrine (OM), a natural quinolizidine alkaloid used clinically for treating hepatitis B, was chosen as a model drug. The surface-modified MVLs and uncoated MVLs were characterized in vitro in terms of their shape, size, zeta potential, entrapment efficiency, coating efficiency, the stability of MVLs in polymer suspension, and the stability in simulated gastric and intestinal fluids. Results: In vivo, the area under the plasma concentration–time curve obtained from the pharmacokinetics study of TMC-coated MVLs was found to be about 3.26- and 1.96-fold higher than that of OM solution and uncoated MVLs, respectively. Conclusion: TMC-coated MVLs can be considered as a potential carrier for oral drug administration.Keywords
This publication has 19 references indexed in Scilit:
- Multivesicular liposome formulation for the sustained delivery of breviscapineInternational Journal of Pharmaceutics, 2005
- Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodiumAAPS PharmSciTech, 2005
- Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- The sustained granulopoietic effect of progenipoietin encapsulated in multivesicular liposomesInternational Journal of Pharmaceutics, 2003
- Oxymatrine therapy for chronic hepatitis B: A randomized double-blind and placebo-controlled multi-center trialWorld Journal of Gastroenterology, 2003
- A lipid based depot (DepoFoam® technology) for sustained release drug deliveryProgress in Lipid Research, 2002
- Sustained-delivery of an apolipoproteinE–peptidomimetic using multivesicular liposomes lowers serum cholesterol levelsJournal of Controlled Release, 2002
- Distribution of Phospholipids and Triglycerides in Multivesicular Lipid ParticlesDrug Delivery, 1999
- Local Treatment of Prosthetic Vascular Graft Infection with Multivesicular Liposome-Encapsulated AmikacinJournal of Surgical Research, 1998
- Pharmacokinetics of DepoFoam Gentamicin Delivery System and Effect on Soft Tissue InfectionJournal of Surgical Research, 1993